Close

A note on cookies

We use cookies to improve your experience of our website. If you want to find out more see our Privacy Policy

Menu

Institute of Bioengineering

Team menu

Dr Anthony Mathur

Department William Harvey Research Institute
Telephone +44 (0) 20 7882 5906
Email a.mathur@qmul.ac.uk
Homepage http://www.qmul.ac.uk/whri/people/academic-staff/items/mathuranthony.html

Research Interests

TBC

Key Publications

Lovell MJ, Yasin M, Lee KL, Cheung KK, Shintani Y, Collino M, Sivarajah A, Leung K-Y, Takahashi K, Kapoor A, Yaqoob MM, Suzuki K, Lythgoe MF, Martin J, Munroe PB, Thiemermann C and Mathur A (2010). Bone marrow mononuclear cells reduce myocardial reperfusion injury by activating the PI3K/Akt survival pathway. Atherosclerosis  vol. 213, (1) 67-76. 10.1016/j.atherosclerosis.2010.07.045

Yeo C, Saunders N, Locca D, Flett A, Preston M, Brookman P, Davy B, Mathur A and Agrawal S (2009). Ficoll-Paque versus Lymphoprep: a comparative study of two density gradient media for therapeutic bone marrow mononuclear cell preparations. Regen Med  vol. 4, (5) 689-696. 10.2217/rme.09.44

Wragg A, Mellad JA, Beltran LE, Konoplyannikov M, San H, Boozer S, Deans RJ, Mathur A, Lederman RJ, Kovacic JC and Boehm M (2008). VEGFR1/CXCR4-positive progenitor cells modulate local inflammation and augment tissue perfusion by a SDF-1-dependent mechanism. J Mol Med (Berl)  vol. 86, (11) 1221-1232. 10.1007/s00109-008-0390-7

Bartunek J, Dimmeler S, Drexler H, Fernandez-Aviles F, Galinanes M, Janssens S, Martin J, Mathur A, Menasche P, Priori S, Strauer B, Tendera M, Wijns W and Zeiher A (2006). The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Eur Heart J  vol. 27, (11) 1338-1340. 10.1093/eurheartj.ehi793

2018

Torii R, Stettler R, Räber L, Zhang Y-J, Karanasos A, Dijkstra J, Patel K, Crake T, Hamshere S, Garcia-Garcia HM, Tenekecioglu E, Ozkor M, Baumbach A, Windecker S, Serruys PW, Regar E, Mathur A and Bourantas CV (2018). Implications of the local hemodynamic forces on the formation and destabilization of neoatherosclerotic lesions. Int J Cardiol  vol. 272, 7-12. 10.1016/j.ijcard.2018.06.065

Jones DA, Rathod KS, Pavlidis AN, Gallagher SM, Astroulakis Z, Lim P, Sirker A, Knight CJ, Dalby MC, Malik IS, Mathur A, Rakhit R, Redwood S, MacCarthy PA, Baker C, Desilva R, Di Mario C, Weerackody R, Hill J, Wragg A and Smith EJ (2018). Outcomes after chronic total occlusion percutaneous coronary interventions: an observational study of 5496 patients from the Pan-London CTO Cohort. Coron Artery Dis  vol. 29, (7) 557-563. 10.1097/MCA.0000000000000644

Timmis A, Raharja A, Archbold RA and Mathur A (2018). Validity of inducible ischaemia as a surrogate for adverse outcomes in stable coronary artery disease. Heart  vol. 104, (21) 1733-1738. 10.1136/heartjnl-2018-313230

Rathod KS, Koganti S, Jain AK, Astroulakis Z, Lim P, Rakhit R, Kalra SS, Dalby MC, O'Mahony C, Malik IS, Knight CJ, Mathur A, Redwood S, Sirker A, MacCarthy PA, Smith EJ, Wragg A and Jones DA (2018). Complete Versus Culprit-Only Lesion Intervention in Patients With Acute?Coronary Syndromes. J Am Coll Cardiol  vol. 72, (17) 1989-1999. 10.1016/j.jacc.2018.07.089

Antoniou S, Colicchia M, Guttmann OP, Rathod KS, Wright P, Fhadil S, Knight CJ, Jain AK, Smith EJ, Mathur A, Weerackody R, Wragg A and Jones DA (2018). Risk scoring to guide antiplatelet therapy post-percutaneous coronary intervention for acute coronary syndrome results in improved clinical outcomes. Eur Heart J Qual Care Clin Outcomes  vol. 4, (4) 283-289. 10.1093/ehjqcco/qcx041

Castle EV, Rathod KS, Guttmann OP, Jenkins AM, McCarthy CD, Knight CJ, O'Mahony C, Mathur A, Smith EJ, Weerackody R, Timmis AD, Wragg A and Jones DA (2018). Routine use of fluoroscopic guidance and up-front femoral angiography results in reduced femoral complications in patients undergoing coronary angiographic procedures: an observational study using an Interrupted Time-Series analysis. Heart Vessels  10.1007/s00380-018-1266-6

Jones DA, Rathod KS, Williamson A, Harrington D, Andiapen M, van Eijl S, Westwood M, Antoniou S, Schilling RJ, Ahluwalia A and Mathur A (2018). The effect of intracoronary sodium nitrite on the burden of ventricular arrhythmias following primary percutaneous coronary intervention for acute myocardial infarction. Int J Cardiol  vol. 266, 1-6. 10.1016/j.ijcard.2018.01.029

Hamshere S, Byrne A, Guttmann O, Rees P, Bourantas C, Weerakody R, Wragg A, Knight C, Mathur A and Jones DA (2018). An observational study of clinical outcomes of everolimus-eluting bioresorbable scaffolds comparing the procedural use of optical coherence tomography against angiography alone. Coron Artery Dis  vol. 29, (6) 482-488. 10.1097/MCA.0000000000000626

Gulati A, Japp AG, Raza S, Halliday BP, Jones DA, Newsome S, Ismail NA, Morarji K, Khwaja J, Spath N, Shakespeare C, Kalra PR, Lloyd G, Mathur A, Cleland JGF, Cowie MR, Assomull RG, Pennell DJ, Ismail TF and Prasad SK (2018). Absence of Myocardial Fibrosis Predicts Favorable Long-Term Survival in New-Onset Heart Failure. Circ Cardiovasc Imaging  vol. 11, (9) 10.1161/CIRCIMAGING.118.007722

Jones DA, Rathod KS, Koganti S, Hamshere S, Astroulakis Z, Lim P, Sirker A, O'Mahony C, Jain AK, Knight CJ, Dalby MC, Malik IS, Mathur A, Rakhit R, Lockie T, Redwood S, MacCarthy PA, Desilva R, Weerackody R, Wragg A, Smith EJ and Bourantas CV (2018). Angiography Alone Versus Angiography?Plus Optical Coherence?Tomography to?Guide Percutaneous?Coronary?Intervention: Outcomes From the Pan-London PCI Cohort. Jacc Cardiovasc Interv  vol. 11, (14) 1313-1321. 10.1016/j.jcin.2018.01.274

Bourantas CV, Ramasamy A, Karagiannis A, Sakellarios A, Zanchin T, Yamaji K, Ueki Y, Shen X, Fotiadis DI, Michalis LK, Mathur A, Serruys PW, Garcia-Garcia HM, Koskinas K, Torii R, Windecker S and Räber L (2018). Angiographic derived endothelial shear stress: a new predictor of atherosclerotic disease progression. Eur Heart J Cardiovasc Imaging  10.1093/ehjci/jey091

Cai J-Z, Zhu Y-X, Wang X-Y, Bourantas CV, Iqbal J, Zhu H, Cummins P, Dong S-J, Mathur A and Zhang Y-J (2018). Comparison of new-generation drug-eluting stents versus drug-coated balloon for in-stent restenosis: a meta-analysis of randomised controlled trials. Bmj Open  vol. 8, (2) 10.1136/bmjopen-2017-017231

Stettler R, Dijkstra J, Räber L, Torii R, Zhang YJ, Karanasos A, Liu S, Crake T, Hamshere S, Garcia-Garcia HM, Tenekecioglu E, Ozkor M, Windecker S, Serruys PW, Regar E, Mathur A and Bourantas CV (2018). Neointima and neoatherosclerotic characteristics in bare metal and first-and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: An optical coherence tomography study. Eurointervention  vol. 13, (15) e1831-e1840. 10.4244/EIJ-D-17-00051

Detela G, Bain OW, Kim H-W, Williams DJ, Mason C, Mathur A and Wall IB (2018). Donor Variability in Growth Kinetics of Healthy hMSCs Using Manual Processing: Considerations for Manufacture of Cell Therapies. Biotechnol J  vol. 13, (2) 10.1002/biot.201700085

Rathod KS, Koganti S, Iqbal MB, Jain AK, Kalra SS, Astroulakis Z, Lim P, Rakhit R, Dalby MC, Lockie T, Malik IS, Knight CJ, Whitbread M, Mathur A, Redwood S, MacCarthy PA, Sirker A, O'Mahony C, Wragg A and Jones DA (2018). Contemporary trends in cardiogenic shock: Incidence, intra-aortic balloon pump utilisation and outcomes from the London Heart Attack Group. Eur Heart J Acute Cardiovasc Care  vol. 7, (1) 16-27. 10.1177/2048872617741735

Baumbach A, Zaman A, West NEJ, O'Kane P, Egred M, Johnson T, Wheatcroft S, Bowles R, de Belder A, Bouras G, Lansky A, Hill J, Mathur A, de Belder MA and Banning AP (2018). Acute and one-year clinical outcomes following implantation of bioresorbable vascular scaffolds: the ABSORB UK Registry. Eurointervention  vol. 13, (13) 1554-1560. 10.4244/EIJ-D-17-00886

Lee JS, Han P, Song E, Kim D, Lee H, Labowsky M, Taavitsainen J, Ylä-Herttuala S, Hytönen J, Gülcher M, Perampaladas K, Sinusas AJ, Martin J, Mathur A and Fahmy TM (2018). Magnetically Coated Bioabsorbable Stents for Renormalization of Arterial Vessel Walls after Stent Implantation. Nano Lett  vol. 18, (1) 272-281. 10.1021/acs.nanolett.7b04096

Hamshere S, Byrne A, Choudhury T, Gallagher SM, Rathod KS, Lungley J, Knight CJ, Kapur A, Jones DA and Mathur A (2018). Randomised trial of the comparison of drug-eluting stents in patients with diabetes: OCT DES trial. Open Heart  vol. 5, (1) 10.1136/openhrt-2017-000705

Fisher SA, Doree C, Mathur A, Taggart DP and Martin-Rendon E (2018). Cochrane Corner: stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Heart  vol. 104, (1) 8-10. 10.1136/heartjnl-2017-311684

2017

Mathur A, Arnold R, Assmus B, Bartunek J, Belmans A, Bönig H, Crea F, Dimmeler S, Dowlut S, Fernández-Avilés F, Galiñanes M, Garcia-Dorado D, Hartikainen J, Hill J, Hogardt-Noll A, Homsy C, Janssens S, Kala P, Kastrup J, Martin J, Menasche P, Miklik R, Mozid A, San Román JA and San (2017). The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trial. Eur J Heart Fail  vol. 19, (11) 1545-1550. 10.1002/ejhf.829

Mathur A, Fernández-Avilés F, Dimmeler S, Hauskeller C, Janssens S, Menasche P, Wojakowski W, Martin JF, Zeiher A and BAMI Investigators (2017). The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016. Eur Heart J  vol. 38, (39) 2930-2935. 10.1093/eurheartj/ehw640

Rathod KS, Antoniou S, Avari P, Ding N, Wright P, Knight C, Jain AK, Mathur A, Smith EJ, Weerackody R, Wragg A and Jones DA (2017). Eptifibatide is associated with significant cost savings and similar clinical outcomes to abciximab when used during primary percutaneous coronary intervention for ST-elevation myocardial infarction: An observational cohort study of 3863 patients. Sage Journals  Jrsm Cardiovasc Dis  vol. 6, 1-8. 10.1177/2048004017734431

Campo G, Pavasini R, Morciano G, Lincoff MA, C Gibson M, Kitakaze M, Lonborg J, Ahluwalia A, Ishii H, Frenneaux M, Ovize M, Galvani M, Atar D, Ibanez B, Cerisano G, Biscaglia S, Neil BJ, Asakura M, Engstrom T, Jones DA, Dawson D, Ferrari R, Pinton P and Ottani F (2017). Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention. Data Brief  vol. 14, 197-205. 10.1016/j.dib.2017.07.033

Campo G, Pavasini R, Morciano G, Lincoff AM, Gibson CM, Kitakaze M, Lonborg J, Ahluwalia A, Ishii H, Frenneaux M, Ovize M, Galvani M, Atar D, Ibanez B, Cerisano G, Biscaglia S, Neil BJ, Asakura M, Engstrom T, Jones DA, Dawson D, Ferrari R, Pinton P and Ottani F (2017). Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials. Int J Cardiol  vol. 244, 59-66. 10.1016/j.ijcard.2017.06.040

Fernández-Avilés F, Sanz-Ruiz R, Climent AM, Badimon L, Bolli R, Charron D, Fuster V, Janssens S, Kastrup J, Kim HS, Lüscher TF, Martin JF, Menasche P, Simari RD, Stone GW, Terzic A, Willerson JT, Wu JC, Joseph CW, Weny T, Broughton K, DiFede DL, Dimmeler S, Madonna R, Penn MS and S (2017). Global position paper on cardiovascular regenerative medicine. European Heart Journal  vol. 38, (33) 2532-2546. 10.1093/eurheartj/ehx248

Rathod KS, Hamshere S, Khambata RS, Andiapen M, Westwood M, Mathur A, Ahluwalia A and Jones DA (2017). Combined analysis of the safety of intra-coronary drug delivery during primary percutaneous coronary intervention for acute myocardial infarction: A study of three clinical trials. Sage Journals  Jrsm Cardiovasc Dis  vol. 6, 20480040177-20480040177. 10.1177/2048004017725988

Davies BM, Smith J, Rikabi S, Wartolowska K, Morrey M, French A, MacLaren R, Williams D, Bure K, Pinedo-Villanueva R, Mathur A, Birchall M, Snyder E, Atala A, Reeve B and Brindley D (2017). A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies. Sage  J Tissue Eng  vol. 8, (1-8) 20417314177-20417314177. 10.1177/2041731417724413

Guttmann OP, Jones DA, Gulati A, Kotecha T, Fayed H, Patel D, Crake T, Ozkor M, Wragg A, Smith EJ, Weerackody R, Knight CJ, Mathur A and O'Mahony C (2017). Prevalence and outcomes of coronary artery perforation during percutaneous coronary intervention. Eurointervention  vol. 13, (5) e595-e601. 10.4244/EIJ-D-16-01038

Michail M, Serruys PW, Stettler R, Crake T, Torii R, Tenekecioglu E, Zeng Y, Onuma Y, Mathur A and Bourantas CV (2017). Intravascular multimodality imaging: feasibility and role in the evaluation of coronary plaque pathology. Eur Heart J Cardiovasc Imaging  vol. 18, (6) 613-620. 10.1093/ehjci/jew330

Patel K, Tarkin J, Serruys PW, Tenekecioglu E, Foin N, Zhang Y-J, Crake T, Moon J, Mathur A and Bourantas CV (2017). Invasive or non-invasive imaging for detecting high-risk coronary lesions? Expert Rev Cardiovasc Ther  vol. 15, (3) 165-179. 10.1080/14779072.2017.1297231

Choudhury T, Mozid A, Hamshere S, Yeo C, Pellaton C, Arnous S, Saunders N, Brookman P, Jain A, Locca D, Archbold A, Knight C, Wragg A, Davies C, Mills P, Parmar M, Rothman M, Choudry F, Jones DA, Agrawal S, Martin J and Mathur A (2017). An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the REGENERATE-IHD clinical trial. Wiley  European Journal of Heart Failure  vol. 19, (1) 138-147. 10.1002/ejhf.676

Jones DA, Rathod KS and Ahluwalia A (2017). Update on Nitrite Reduction in Ischemic Disease: Mechanisms and Clinical Translation. Nitric Oxide: Biology and Pathobiology: Third Edition  10.1016/B978-0-12-804273-1.00015-6

2016

Fisher SA, Doree C, Mathur A, Taggart DP and Martin-Rendon E (2016). Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database Syst Rev  vol. 12, 10.1002/14651858.CD007888.pub3

Ott C, Lobo MD, Sobotka PA, Mahfoud F, Stanton A, Cockcroft J, Sulke N, Dolan E, van der Giet M, Hoyer J, Furniss SS, Foran JP, Witkowski A, Januszewicz A, Schoors D, Tsioufis K, Rensing BJ, Saxena M, Scott B, Ng GA, Achenbach S and Schmieder RE (2016). Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension. American Heart Association, Inc.  J Am Heart Assoc  vol. 5, (12) 10.1161/JAHA.116.004234

Rathod KS, Jones DA, Van-Eijl TJA, Tsang H, Warren H, Hamshere SM, Kapil V, Jain AK, Deaner A, Poulter N, Caulfield MJ, Mathur A and Ahluwalia A (2016). Randomised, double-blind, placebo-controlled study investigating the effects of inorganic nitrate on vascular function, platelet reactivity and restenosis in stable angina: protocol of the NITRATE-OCT study. Bmj Open  vol. 6, (12) 10.1136/bmjopen-2016-012728

Keeble TR, Khokhar A, Akhtar MM, Mathur A, Weerackody R and Kennon S (2016). Percutaneous balloon aortic valvuloplasty in the era of transcatheter aortic valve implantation: A narrative review. Open Heart  vol. 3, (2) 10.1136/openhrt-2016-000421

Farlik M, Halbritter F, Müller F, Choudry FA, Ebert P, Klughammer J, Farrow S, Santoro A, Ciaurro V, Mathur A, Uppal R, Stunnenberg HG, Ouwehand WH, Laurenti E, Lengauer T, Frontini M and Bock C (2016). DNA Methylation Dynamics of Human Hematopoietic Stem Cell Differentiation. Cell Stem Cell  vol. 19, (6) 808-822. 10.1016/j.stem.2016.10.019

Jones DA, Khambata RS, Andiapen M, Rathod KS, Mathur A and Ahluwalia A (2016). Intracoronary nitrite suppresses the inflammatory response following primary percutaneous coronary intervention. Heart  10.1136/annrheumdis-2016-309748

Jones DA, Khambata RS, Andiapen M, Rathod KS, Mathur A and Ahluwalia A (2016). Intracoronary nitrite suppresses the inflammatory response following primary percutaneous coronary intervention. Bmj Publishing Group  Heart  10.1136/heartjnl-2016-309748

Saxena M, Sobotka PA, Hamshere SM, Jain A, Mathur A, Knight C, Collier DJ and Lobo MD (2016). Antihypertensive Effects of a Central Arteriovenous Anastomosis Are Mediated Through Profound Reduction in Systemic Vascular Resistance. Circ Cardiovasc Interv  vol. 9, (8) 10.1161/CIRCINTERVENTIONS.116.004012

SUZUKI K, Campbell N and Mathur A (2016). Cell Size Critically Determines Initial Retention of Bone Marrow Mononuclear Cells in the Heart after Intracoronary Injection: Evidence from A Rat Model. Public Library of Science  Plos One  vol. 11, (7) 10.1371/journal.pone.0158232

Fisher SA, Doree C, Taggart DP, Mathur A and Martin-Rendon E (2016). Cell therapy for heart disease: Trial sequential analyses of two Cochrane reviews. American Society For Clinical Pharmacology and Therapeutics  Clinical Pharmacology and Therapeutics  vol. 100, (1) 88-101. 10.1002/cpt.344

Burchell AE, Chan K, Ratcliffe LEK, Hart EC, Saxena M, Collier DJ, Jain AK, Mathur A, Knight CJ, Caulfield MJ, Paton JFR, Nightingale AK, Lobo MD and Baumbach A (2016). Controversies Surrounding Renal Denervation: Lessons Learned From Real-World Experience in Two United Kingdom Centers. J Clin Hypertens (Greenwich)  vol. 18, (6) 585-592. 10.1111/jch.12789

Rathod KS, Jones DA, Gallagher S, Rathod VS, Weerackody R, Jain AK, Mathur A, Mohiddin SA, Archbold RA, Wragg A and Knight CJ (2016). Atypical risk factor profile and excellent long-term outcomes of young patients treated with primary percutaneous coronary intervention for ST-elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care  vol. 5, (1) 23-32. 10.1177/2048872614567453

Hamshere S, Jones DA, Pellaton C, Longchamp D, Burchell T, Mohiddin S, Moon JC, Kastrup J, Locca D, Petersen SE, Westwood M and Mathur A (2016). Cardiovascular magnetic resonance imaging of myocardial oedema following acute myocardial infarction: Is whole heart coverage necessary? J Cardiovasc Magn Reson  vol. 18, 10.1186/s12968-016-0226-5

Choudry F, Hamshere S, Saunders N, Veerapen J, Bavnbek K, Knight C, Pellerin D, Locca D, Westwood M, Rakhit R, Crake T, Kastrup J, Parmar M, Agrawal S, Jones D, Martin J and Mathur A (2016). A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial?. Eur Heart J  vol. 37, (3) 256-263. 10.1093/eurheartj/ehv493

Guttmann OP, Jones DA, Safwan KA, Gallagher S, Rathod KS, Hamshere S, Smith EJ, Jain AK, Mathur A, Wragg A, Knight CJ and Weerackody R (2016). Drug-eluting stents appear superior to bare metal stents for vein-graft PCI in vessels up to a stent diameter of 4 mm. Heart Int  vol. 11, (1) e17-e24. 10.5301/heartint.5000228

Pavlidis AN, Jones DA, Sirker A, Mathur A and Smith EJ (2016). Reducing radiation in chronic total occlusion percutaneous coronary interventions. Curr Cardiol Rev  vol. 12, (1) 12-17. 10.2174/1573403X11666150407110849

2015

Hamshere S, Arnous S, Choudhury T, Choudry F, Mozid A, Yeo C, Barrett C, Saunders N, Gulati A, Knight C, Locca D, Davies C, Cowie MR, Prasad S, Parmar M, Agrawal S, Jones D, Martin J, McKenna W and Mathur A (2015). Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial. European Heart Journal  vol. 36, (44) 3061-3069. 10.1093/eurheartj/ehv390

Hamshere S, Arnous S, Choudhury T, Choudry F, Mozid A, Yeo C, Barrett C, Saunders N, Gulati A, Knight C, Locca D, Davies C, Cowie MR, Prasad S, Parmar M, Agrawal S, Jones D, Martin J, McKenna W and Mathur A (2015). Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial. Eur Heart J  vol. 36, (44) 3061-3069. 10.1093/eurheartj/ehv390

Verhoef TI, Morris S, Mathur A and Singer M (2015). Potential economic consequences of a cardioprotective agent for patients with myocardial infarction: modelling study. Bmj Open  vol. 5, (11) 10.1136/bmjopen-2015-008164

Lobo MD, Sobotka PA, Dolan E, Witkowski A, Schmieder RE and ROX CONTROL HTN Investigators (2015). Central arteriovenous anastomosis and hypertension - Authors' reply. Lancet  vol. 386, (10006) 1821-1822. 10.1016/S0140-6736(15)00762-X

Saxena M, Collier D, Jain A, Mathur A, Knight C, Sobotka P and Lobo M (2015). A central iliac arteriovenous anastomosis results in durable and substantial blood pressure reduction in a woman with uncontrolled hypertension and multiple antihypertensive drug intolerances. Journal of Human Hypertension  vol. 29, (10) 631-632.

Kapil V, Sobotka PA, Saxena M, Mathur A, Knight C, Dolan E, Stanton A and Lobo MD (2015). Central iliac arteriovenous anastomosis for hypertension: targeting mechanical aspects of the circulation. Curr Hypertens Rep  vol. 17, (9) 10.1007/s11906-015-0585-6

Michail M, Torii R, Crake T, Ozkor M, Garcia-Garcia HM, Tenekecioglu E, Onuma Y, Mathur A, Serruys PW and Bourantas CV (2015). Local Hemodynamics: An Innocent Bystander or a Critical Factor Regulating Neoatherosclerotic Evolution? Jacc Cardiovasc Interv  vol. 8, (9) e149-e150. 10.1016/j.jcin.2015.04.022

Choudry FA, Weerackody RP, Timmis AD, Wragg A, Mathur A, Sporton S, Mills PG and Jain AK (2015). Importance of primary percutaneous coronary intervention for reducing mortality in ST-elevation myocardial infarction complicated by out of hospital cardiac arrest. Eur Heart J Acute Cardiovasc Care  vol. 4, (4) 378-385. 10.1177/2048872614555990

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM and IMPROVE-IT Investigators (2015). Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med  vol. 372, (25) 2387-2397. 10.1056/NEJMoa1410489

Iqbal MB, Khamis R, Ilsley C, Mikhail G, Crake T, Firoozi S, Kalra S, Knight C, Archbold A, Lim P, Mathur A, Meier P, Rakhit RD, Redwood S, Whitbread M, Bromage D, Rathod K, Jones DA, Wragg A, Dalby M, MacCarthy P, Malik IS and London Heart Attack Centre Group Investigators (2015). Time-trend analyses of bleeding and mortality after primary percutaneous coronary intervention during out of working hours versus in-working hours: an observational study of 11 466 patients. Circ Cardiovasc Interv  vol. 8, (6) 10.1161/CIRCINTERVENTIONS.114.002206

Choudry FA, Yeo C, Mozid A, Martin JF and Mathur A (2015). Increases in plasma T?4 after intracardiac cell therapy in chronic ischemic heart failure is associated with symptomatic improvement. Regen Med  vol. 10, (4) 403-410. 10.2217/rme.15.9

Bulluck H, Fröhlich GM, Mohdnazri S, Gamma RA, Davies JR, Clesham GJ, Sayer JW, Aggarwal RK, Tang KH, Kelly PA, Jagathesan R, Kabir A, Robinson NM, Sirker A, Mathur A, Blackman DJ, Ariti C, Krishnamurthy A, White SK, Meier P, Moon JC, Greenwood JP and Hausenloy DJ (2015). Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design. Clin Cardiol  vol. 38, (5) 259-266. 10.1002/clc.22401

Lobo MD, Sobotka PA, Stanton A, Cockcroft JR, Sulke N, Dolan E, van der Giet M, Hoyer J, Furniss SS, Foran JP, Witkowski A, Januszewicz A, Schoors D, Tsioufis K, Rensing BJ, Scott B, Ng GA, Ott C, Schmieder RE and ROX CONTROL HTN Investigators (2015). Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial. Lancet  vol. 385, (9978) 1634-1641. 10.1016/S0140-6736(14)62053-5

Jones DA, Rathod KS, Gallagher S, Jain AK, Kalra SS, Lim P, Crake T, Ozkor M, Rakhit R, Knight CJ, Iqbal MB, Dalby MC, Malik IS, Whitbread M, Mathur A, Redwood S, MacCarthy PA, Weerackody R and Wragg A (2015). Manual Thrombus Aspiration Is Not Associated With Reduced Mortality in?Patients Treated With Primary Percutaneous Coronary Intervention: An Observational Study of 10,929 Patients With ST-Segment?Elevation Myocardial Infarction From the London?Heart?Attack. Jacc Cardiovasc Interv  vol. 8, (4) 575-584. 10.1016/j.jcin.2014.11.021

Fisher SA, Doree C, Mathur A and Martin-Rendon E (2015). Meta-analysis of cell therapy trials for patients with heart failure. Circ Res  vol. 116, (8) 1361-1377. 10.1161/CIRCRESAHA.116.304386

Fisher SA, Doree C, Mathur A and Martin-Rendon E (2015). Meta-analysis of cell therapy trials for patients with heart failure. Circulation Research  vol. 116, (8) 1361-1377. 10.1161/CIRCRESAHA.116.304386

Pavlidis AN, Jones DA, Sirker A, Mathur A and Smith EJ (2015). Prevention of contrast-induced acute kidney injury after percutaneous coronary intervention for chronic total coronary occlusions. Am J Cardiol  vol. 115, (6) 844-851. 10.1016/j.amjcard.2014.12.047

Rathod KS, Jones DA, Bromage DI, Gallagher SM, Rathod VS, Kennon S, Knight C, Rothman MT, Mathur A, Smith E, Jain AK, Archbold RA and Wragg A (2015). Radial primary percutaneous coronary intervention is independently associated with decreased long-term mortality in high-risk ST-elevation myocardial infarction patients. J Cardiovasc Med (Hagerstown)  vol. 16, (3) 170-177. 10.2459/JCM.0000000000000230

Rathod KS, Hamshere SM, Jones DA and Mathur A (2015). Intravascular Ultrasound Versus Optical Coherence Tomography for Coronary Artery Imaging - Apples and Oranges? Interv Cardiol  vol. 10, (1) 8-15. 10.15420/icr.2015.10.1.8

Gallagher SM, Jones DA, Kapur A, Wragg A, Harwood SM, Mathur R, Archbold RA, Uppal R and Yaqoob MM (2015). Remote ischemic preconditioning has a neutral effect on the incidence of kidney injury after coronary artery bypass graft surgery. Kidney International  vol. 87, (2) 473-481. 10.1038/ki.2014.259

Jones D, Howard J, Rathod K, Gallagher S, Knight C, Jain A, Mathur A, Mohiddin S, Mills P, Timmis A, Archbold R and Wragg A (2015). . The impact of socioeconomic status on all-cause mortality after percutaneous coronary intervention: an observational cohort study of 13,770 patients. Europa Digital & Publishing  Eurointervention : Journal of Europcr in Collaboration With The Working Group On Interventional Cardiology of The European Socie  vol. 10, (10) e1-e8. 10.4244/EIJV10I10A196

Gallagher SM, Jones DA, Kapur A, Wragg A, Harwood SM, Mathur R, Archbold RA, Uppal R and Yaqoob MM (2015). Remote ischemic preconditioning has a neutral effect on the incidence of kidney injury after coronary artery bypass graft surgery. Kidney Int  vol. 87, (2) 473-481. 10.1038/ki.2014.259

Jones DA, Pellaton C, Velmurugan S, Rathod KS, Andiapen M, Antoniou S, van Eijl S, Webb AJ, Westwood MA, Parmar MK, Mathur A and Ahluwalia A (2015). Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction. Circ Res  vol. 116, (3) 437-447. 10.1161/CIRCRESAHA.116.305082

Michail M, Torii R, Crake T, Ozkor M, Garcia-Garcia HM, Tenekecioglu E, Onuma Y, Mathur A, Serruys PW and Bourantas CV (2015). Local Hemodynamics An Innocent Bystander or a Critical Factor Regulating Neoatherosclerotic Evolution? Jacc: Cardiovascular Interventions  vol. 8, (9) e149-e150. 10.1016/j.jcin.2015.04.022

Jones DA, Pellaton C, Velmurugan S, Rathod KS, Andiapen M, Antoniou S, Van Eijl S, Webb AJ, Westwood MA, Parmar MK, Mathur A and Ahluwalia A (2015). Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction. Circulation Research  vol. 116, (3) 437-447. 10.1161/CIRCRESAHA.116.305082

2014

Jones DA, Pellaton C, Velmurugan S, Andiapen M, Antoniou S, Van Eiji S, Westwood MA, Webb AJ, Mathur A and Ahluwalia A (2014). The safety and efficacy of intra-coronary nitrite infusion during acute myocardial infarction (NITRITE-AMI): A single centre, randomised, double-blind controlled trial. Nitric Oxide-Biology and Chemistry  vol. 42, 127-128. 10.1016/j.niox.2014.09.087

Iqbal MB, Ilsley C, Kabir T, Smith R, Lane R, Mason M, Clifford P, Crake T, Firoozi S, Kalra S, Knight C, Lim P, Malik IS, Mathur A, Meier P, Rakhit RD, Redwood S, Whitbread M, Bromage D, Rathod K, MacCarthy P, Dalby M and London Heart Attack Centre (HAC) Group Investigators (2014). Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London. Circ Cardiovasc Qual Outcomes  vol. 7, (6) 936-943. 10.1161/CIRCOUTCOMES.114.001194

Gallagher SM, Lovell MJ, Jones DA, Ferguson E, Ahktar A, Buckhoree Z, Wragg A, Knight CJ, Mathur A, Smith EJ, Cliffe S, Archbold RA, Rothman MT and Jain AK (2014). Does a 'direct' transfer protocol reduce time to coronary angiography for patients with non-ST-elevation acute coronary syndromes? A prospective observational study. Bmj Open  vol. 4, (9) 10.1136/bmjopen-2014-005525

Iqbal MB, Arujuna A, Ilsley C, Archbold A, Crake T, Firoozi S, Kalra S, Knight C, Lim P, Malik IS, Mathur A, Meier P, Rakhit RD, Redwood S, Whitbread M, Bromage D, Rathod K, Wragg A, MacCarthy P, Dalby M and London Heart Attack Centre (HAC) Group Investigators (2014). Radial versus femoral access is associated with reduced complications and mortality in patients with non-ST-segment-elevation myocardial infarction: an observational cohort study of 10,095 patients. Circ Cardiovasc Interv  vol. 7, (4) 456-464. 10.1161/CIRCINTERVENTIONS.114.001314

Mozid AM, Holstensson M, Choudhury T, Ben-Haim S, Allie R, Martin J, Sinusas AJ, Hutton BF and Mathur A (2014). Clinical feasibility study to detect angiogenesis following bone marrow stem cell transplantation in chronic ischaemic heart failure. Nucl Med Commun  vol. 35, (8) 839-848. 10.1097/MNM.0000000000000130

Rathod KS, Jones DA, Bromage DI, Gallagher SM, Rathod VS, Kennon S, Knight C, Rothman MT, Mathur A, Smith E, Jain AK, Archbold RA and Wragg A (2014). Radial primary percutaneous coronary intervention is independently associated with decreased long-term mortality in high-risk ST-elevation myocardial infarction patients. J Cardiovasc Med (Hagerstown)  10.2459/JCM.0000000000000122

Howard JP, Antoniou S, Jones DA and Wragg A (2014). Recent advances in antithrombotic treatment for acute coronary syndromes. Expert Rev Clin Pharmacol  vol. 7, (4) 507-521. 10.1586/17512433.2014.923306

Gallagher S, Kapur A, Lovell MJ, Jones DA, Kirkwood A, Hassan S, Archbold RA, Wragg A, Uppal R and Yaqoob MM (2014). Impact of diabetes mellitus and renal insufficiency on 5-year mortality following coronary artery bypass graft surgery: a cohort study of 4869 UK patients. Eur J Cardiothorac Surg  vol. 45, (6) 1075-1081. 10.1093/ejcts/ezt630

Mozid A, Yeo C, Arnous S, Ako E, Saunders N, Locca D, Brookman P, Archbold RA, Rothman M, Mills P, Agrawal S, Martin J and Mathur A (2014). Safety and feasibility of intramyocardial versus intracoronary delivery of autologous cell therapy in advanced heart failure: the REGENERATE-IHD pilot study. Regen Med  vol. 9, (3) 269-278. 10.2217/rme.14.3

Awad W, Mathur A, Baldock L, Oliver S and Kennon S (2014). Comparing post-operative resource consumption following transcatheter aortic valve implantation (TAVI) and conventional aortic valve replacement in the UK. J Med Econ  vol. 17, (5) 357-364. 10.3111/13696998.2014.904322

Jones DA, Gallagher S, Rathod KS, Redwood S, de Belder MA, Mathur A, Timmis AD, Ludman PF, Townend JN, Wragg A and NICOR (National Institute for Cardiovascular Outcomes Research) (2014). Mortality in South Asians and Caucasians after percutaneous coronary intervention in the United Kingdom: an observational cohort study of 279,256 patients from the BCIS (British Cardiovascular Intervention Society) National Database. Jacc Cardiovasc Interv  vol. 7, (4) 362-371. 10.1016/j.jcin.2013.11.013

Hamshere S, Choudhury T, Jones DA, Locca D, Mills P, Rothman M, Knight C, Parmar M, Agrawal S, Martin J and Mathur A (2014). A randomised double-blind control study of early intracoronary autologous bone marrow cell infusion in acute myocardial infarction (REGENERATE-AMI). Bmj Open  vol. 4, (2) 10.1136/bmjopen-2013-004258

Bain O, Detela G, Kim H-W, Mason C, Mathur A and Wall IB (2014). Altered hMSC functional characteristics in short-term culture and when placed in low oxygen environments: implications for cell retention at physiologic sites. Regen Med  vol. 9, (2) 153-165. 10.2217/rme.13.91

Gallagher S, Jones DA, Lovell MJ, Hassan S, Wragg A, Kapur A, Uppal R and Yaqoob MM (2014). The impact of acute kidney injury on midterm outcomes after coronary artery bypass graft surgery: A matched propensity score analysis. Journal of Thoracic and Cardiovascular Surgery  vol. 147, (3) 989-995. 10.1016/j.jtcvs.2013.03.016

Hamshere S, Choudhury T, Jones DA, Locca D, Mills P, Rothman M, Knight C, Parmar M, Agrawal S, Martin J and Mathur A (2014). A randomised double-blind control study of early intracoronary autologous bone marrow cell infusion in acute myocardial infarction (REGENERATE-AMI). Bmj Open  vol. 4, (2) 10.1136/bmjopen-2013-004258

Rathod KS, Jones DA, Rathod VS, Bromage D, Guttmann O, Gallagher SM, Mohiddin S, Rothman MT, Knight C, Jain AK, Kapur A, Mathur A, Timmis AD, Amersey R and Wragg A (2014). Prognostic impact of anaemia on patients with ST-elevation myocardial infarction treated by primary PCI. Coron Artery Dis  vol. 25, (1) 52-59. 10.1097/MCA.0000000000000038

Rossi A, Dharampal A, Wragg A, Davies LC, van Geuns RJ, Anagnostopoulos C, Klotz E, Kitslaar P, Broersen A, Mathur A, Nieman K, Hunink MGM, de Feyter PJ, Petersen SE and Pugliese F (2014). Diagnostic performance of hyperaemic myocardial blood flow index obtained by dynamic computed tomography: does it predict functionally significant coronary lesions? Eur Heart J Cardiovasc Imaging  vol. 15, (1) 85-94. 10.1093/ehjci/jet133

O'Mahony C, Rothman M and Mathur A (2014). A clinical update on the use of resolute stents with dual anti-platelet therapy interruption. Interventional Cardiology  vol. 6, (5) 453-462. 10.2217/ica.14.47

Detela G, Bain O, Mathur A and Wall I (2014). MOLECULAR PATHWAYS CONTROLLING CELL RETENTION AND FUNCTION OF MSCS FOR ISCHEMIC INJURY. Wound Repair and Regeneration  vol. 22, (5) A77-A77.

Davies BM, Rikabi S, French A, Pinedo-Villanueva R, Morrey ME, Wartolowska K, Judge A, MacLaren RE, Mathur A, Williams DJ, Wall I, Birchall M, Reeve B, Atala A, Barker RW, Cui Z, Furniss D, Bure K, Snyder EY, Karp JM, Price A, Carr A and Brindley DA (2014). Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study. J Tissue Eng  vol. 5, 10.1177/2041731414551764

Rathod KS, Hamshere SM, Choudhury TR, Jones DA and Mathur A (2014). Use of thrombectomy devices in primary percutaneous interventions for ST-elevation myocardial infarction - An update. Interventional Cardiology Review  vol. 9, (2) 102-107. 10.15420/icr.2011.9.2.102

Howard JP, Jones DA, Gallagher S, Rathod K, Antoniou S, Wright P, Knight C, Mathur A, Weerackody R and Wragg A (2014). Glycoprotein IIb/IIIa inhibitors use and outcome after percutaneous coronary intervention for non-ST elevation myocardial infarction. Biomed Res Int  vol. 2014, 10.1155/2014/643981

Rathod KS, Jones DA, Rathod VS, Bromage D, Guttmann O, Gallagher SM, Mohiddin S, Rothman MT, Knight C, Jain AK, Kapur A, Mathur A, Timmis AD, Amersey R and Wragg A (2014). Prognostic impact of anaemia on patients with ST-elevation myocardial infarction treated by primary PCI. Coronary Artery Disease  vol. 25, (1) 52-59. 10.1097/MCA.0000000000000038

2013

Jones DA, Gallagher S, Rathod KS, Akhtar M, Knight CJ, Rothman MT, Kapur A, Mathur A, Jain AK, Timmis AD, Smith EJ and Wragg A (2013). Contemporary analysis of incidence and outcomes of stent thrombosis presenting as ST elevation myocardial infarction in a primary percutaneous coronary intervention cohort. Am J Cardiol  vol. 112, (9) 1347-1354. 10.1016/j.amjcard.2013.07.002

Awad W, Mathur A, Baldock L, Oliver S and Kennon S (2013). REAL WORLD RESOURCE USE ASSOCIATED WITH TRANSCATHETER AORTIC VALVE IMPLANTATION AND CONVENTIONAL AORTIC VALVE REPLACEMENT SURGERY. Value in Health  vol. 16, (7) A531-A532. 10.1016/j.jval.2013.08.1315

Jones DA, Gallagher S, Rathod KS, Akhtar M, Knight CJ, Rothman MT, Kapur A, Mathur A, Jain AK, Timmis AD, Smith EJ and Wragg A (2013). Contemporary analysis of incidence and outcomes of stent thrombosis presenting as ST elevation myocardial infarction in a primary percutaneous coronary intervention cohort. American Journal of Cardiology  vol. 112, (9) 1347-1354. 10.1016/j.amjcard.2013.07.002

Jones DA, Gallagher S, Rathod K, Jain AK, Mathur A, Uppal R, Westwood M, Wong K, Rothman MT, Shipolini A, Smith EJ, Mills PG, Timmis AD, Knight CJ, Archbold RA and Wragg A (2013). Clinical outcomes after myocardial revascularization according to operator training status: cohort study of 22,697 patients undergoing percutaneous coronary intervention or coronary artery bypass graft surgery. Eur Heart J  vol. 34, (37) 2887-2895. 10.1093/eurheartj/eht161

Jones DA, Timmis A and Wragg A (2013). Novel drugs for treating angina. Bmj  vol. 347, 10.1136/bmj.f4726

Malcolme-Lawes LC, Juli C, Karim R, Bai W, Quest R, Lim PB, Jamil-Copley S, Kojodjojo P, Ariff B, Davies DW, Rueckert D, Francis DP, Hunter R, Jones D, Boubertakh R, Petersen SE, Schilling R, Kanagaratnam P and Peters NS (2013). Automated analysis of atrial late gadolinium enhancement imaging that correlates with endocardial voltage and clinical outcomes: a 2-center study. Heart Rhythm  vol. 10, (8) 1184-1191. 10.1016/j.hrthm.2013.04.030

Rathod KS, Jones DA, Gallagher SM, Bromage DI, Whitbread M, Archbold AR, Jain AK, Mathur A, Wragg A and Knight CJ (2013). Out-of-hours primary percutaneous coronary intervention for ST-elevation myocardial infarction is not associated with excess mortality: a study of 3347 patients treated in an integrated cardiac network. Bmj Open  vol. 3, (6) 10.1136/bmjopen-2013-003063

Jones DA, Choudry F and Mathur A (2013). Almanac 2012, cell therapy in cardiovascular disease: the journals present selected research that has driven recent advances in clinical cardiology. Anadolu Kardiyol Derg  10.5152/akd.2013.167

Pain TE, Jones DA, Rathod KS, Gallagher SM, Knight CJ, Mathur A, Rothman MT, Jain AK and Wragg A (2013). Influence of female sex on long-term mortality after acute coronary syndromes treated by percutaneous coronary intervention: a cohort study of 7304 patients. Coron Artery Dis  vol. 24, (3) 183-190. 10.1097/MCA.0b013e32835d75f0

Jones DA, Rathod KS, Gallagher S, Weerackody R, Knight CJ, Rothman MT, Mathur A, Jain AK, Timmis AD and Wragg A (2013). Deployment of drug-eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: a 5-year observational cohort study. Catheter Cardiovasc Interv  vol. 81, (6) E237-E244. 10.1002/ccd.24513

Jones DA, Choudry F and Mathur A (2013). Almanac 2012: cell therapy in cardiovascular disease. the national society journals present selected research that has driven recent advances in clinical cardiology. Hellenic J Cardiol  vol. 54, (3) 159-167.

Choudhury TR and Mathur A (2013). The birth of 'regenerative pharmacology': a clinical perspective. Br J Pharmacol  vol. 169, (2) 239-246. 10.1111/bph.12128

Jones DA, Choudry F and Mathura A (2013). Almanac 2012: Cell therapy in cardiovascular disease. The national society journals present selected research that has driven recent advances in clinical cardiology. Arch Cardiol Mex  vol. 83, (2) 130-137. 10.1016/j.acmx.2013.01.007

Hunter RJ, Jones DA, Boubertakh R, Malcolme-Lawes LC, Kanagaratnam P, Juli CF, Davies DW, Peters NS, Baker V, Earley MJ, Sporton S, Davies LC, Westwood M, Petersen SE and Schilling RJ (2013). Diagnostic accuracy of cardiac magnetic resonance imaging in the detection and characterization of left atrial catheter ablation lesions: a multicenter experience. J Cardiovasc Electrophysiol  vol. 24, (4) 396-403. 10.1111/jce.12063

Mozid AM, Jones D, Arnous S, Saunders N, Wragg A, Martin J, Agrawal S and Mathur A (2013). The effects of age, disease state, and granulocyte colony-stimulating factor on progenitor cell count and function in patients undergoing cell therapy for cardiac disease. Stem Cells Dev  vol. 22, (2) 216-223. 10.1089/scd.2012.0139

Jones DA, McGill L-A, Rathod KS, Matthews K, Gallagher S, Uppal R, Mills PG, Das S, Yaqoob M, Ashman N and Wragg A (2013). Characteristics and outcomes of dialysis patients with infective endocarditis. Nephron Clin Pract  vol. 123, (3-4) 151-156. 10.1159/000353732

Fisher SA, Dorée C, Brunskill SJ, Mathur A and Martin-Rendon E (2013). Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis. Plos One  vol. 8, (6) 10.1371/journal.pone.0064669

Jones DA, Andiapen M, Van-Eijl TJA, Webb AJ, Antoniou S, Schilling RJ, Ahluwalia A and Mathur A (2013). The safety and efficacy of intracoronary nitrite infusion during acute myocardial infarction (NITRITE-AMI): study protocol of a randomised controlled trial. Bmj Open  vol. 3, (4) 10.1136/bmjopen-2013-002813

2012

Iglesias JF, Tapponnier M, Hullin R, Vassalli G, Eeckhout E, Vogt P, Mathur A and Locca D (2012). Cell-based regenerative therapy in cardiology: The future at present. Revue Medicale Suisse  vol. 8, (365) 2364-2369.

MATHUR A, Iglesias D, Tapponnier M, Hullin R, Eeckhout E, Vogt P and Locca D (2012). [Cell-based regenerative therapy in cardiology: the future at present]. Rev Med Suisse  vol. 365, (8) 2364-2369.

Jones DA, Rathod KS, Howard JP, Gallagher S, Antoniou S, De Palma R, Guttmann O, Cliffe S, Colley J, Butler J, Ferguson E, Mohiddin S, Kapur A, Knight CJ, Jain AK, Rothman MT, Mathur A, Timmis AD, Smith EJ and Wragg A (2012). Safety and feasibility of hospital discharge 2 days following primary percutaneous intervention for ST-segment elevation myocardial infarction. Heart  vol. 98, (23) 1722-1727. 10.1136/heartjnl-2012-302414

MATHUR A, Schwartz CG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chairman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurry JJ, Mundi H, Nicholls SJ, Shah PK, Tarfif JC and Wright RS (2012). Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med  vol. 22, (367) 2089-2099. 10.1056/NEJMoa1206797

Martin JF, Kristensen SD, Mathur A, Grove EL and Choudry FA (2012). The causal role of megakaryocyte?platelet hyperactivity in acute coronary syndromes. Nat Rev Cardiol  vol. 9, (11) 658-670. 10.1038/nrcardio.2012.131

Jones DA, Choudry F and Mathur A (2012). Cell therapy in cardiovascular disease: the national society journals present selected research that has driven recent advances in clinical cardiology. Heart  vol. 98, (22) 1626-1631. 10.1136/heartjnl-2011-301540

Roe MT, Armstrong PW, Fox KAA, White HD, Prabhakaran D, Goodman SG, Cornel JH, Bhatt DL, Clemmensen P, Martinez F, Ardissino D, Nicolau JC, Boden WE, Gurbel PA, Ruzyllo W, Dalby AJ, McGuire DK, Leiva-Pons JL, Parkhomenko A, Gottlieb S, Topacio GO, Hamm C, Pavlides G, Goudev AR and (2012). Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. New England Journal of Medicine  vol. 367, (14) 1297-1309. 10.1056/NEJMoa1205512

Gallagher S, Jones DA, Anand V and Mohiddin S (2012). Diagnosis and management of patients with acute cardiac symptoms, troponin elevation and culprit-free angiograms. Heart  vol. 98, (13) 974-981. 10.1136/heartjnl-2011-301121

Jones DA, Weerackody R, Rathod K, Behar J, Gallagher S, Knight CJ, Kapur A, Jain AK, Rothman MT, Thompson CA, Mathur A, Wragg A and Smith EJ (2012). Successful Recanalization of Chronic Total Occlusions Is Associated With Improved Long-Term Survival. Jacc-Cardiovascular Interventions  vol. 5, (4) 380-388. 10.1016/j.jcin.2012.01.012

Jones DA, Rathod KS, Sekhri N, Junghans C, Gallagher S, Rothman MT, Mohiddin S, Kapur A, Knight C, Archbold A, Jain AK, Mills PG, Uppal R, Mathur A, Timmis AD and Wragg A (2012). Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary intervention. Heart  vol. 98, (5) 414-419. 10.1136/heartjnl-2011-300130

Clifford DM, Fisher SA, Brunskill SJ, Doree C, Mathur A, Watt S and Martin-Rendon E (2012). Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev  (2) 10.1002/14651858.CD006536.pub3

Arnous S, Mozid A, Martin J and Mathur A (2012). Bone marrow mononuclear cells and acute myocardial infarction. Stem Cell Res Ther  vol. 3, (1) 10.1186/scrt93

Jones DA and Jain AK (2012). Erratum: Percutaneous balloon pericardiotomy for recurrent malignant pericardial effusion (Journal of Thoracic Oncology (2011) 6 (2138-2139)). Journal of Thoracic Oncology  vol. 7, (2) 10.1097/JTO.0b013e3182432222

Clifford DM, Fisher SA, Brunskill SJ, Doree C, Mathur A, Clarke MJ, Watt SM and Martin-Rendon E (2012). Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes. Plos One  vol. 7, (5) 10.1371/journal.pone.0037373

Clifford DM, Fisher SA, Brunskill SJ, Dorée C, Mathur A, Watt S and Martin-Rendon E (2012). Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev  vol. 2, 10.1002/14651858.CD006536.pub3.

2011

Jones DA and Jain AK (2011). Percutaneous balloon pericardiotomy for recurrent malignant pericardial effusion. J Thorac Oncol  vol. 6, (12) 2138-2139. 10.1097/JTO.0b013e318230860e

Graham A, Akhtar MM, Jones D, Rathod K, Gallagher S, Jain A, Mohiddin S, Knight C, Mathur A and Wragg A (2011). In-Stent Restenosis (ISR) is Not Simply a Benign Clinical Entity as It Presents as an Acute Coronary Syndrome (ACS) in 40% of Cases. Circulation  vol. 124, (21)

Akhtar MM, Graham A, Jones D, Rathod K, Gallagher S, Jain A, Mohiddin S, Knight C, Mathur A and Wragg A (2011). Treatment of Multi-Vessel Coronary Artery Disease (CAD) in Primary Percutaneous Coronary Intervention (PPCI) for ST segment Elevation Myocardial Infarction (STEMI): Culprit Only Revascularization is Associated with Higher Major Adverse Cardiovascular Even. Circulation  vol. 124, (21)

Graham A, Akhtar MM, Jones D, Rathod K, Gallagher S, Jain A, Mohiddin S, Knight C, Mathur A and Wragg A (2011). Drug Eluting Stents versus Bare Metal Stents in Large Coronary Arteries During Primary Percutaneous Coronary Intervention. Circulation  vol. 124, (21)

Akhtar MM, Graham A, Jones D, Rathod K, Gallagher S, Jain A, Mohiddin S, Knight C, Mathur A and Wragg A (2011). Acute Stent Thrombosis Resulting in St Elevation Myocardial Infarction (STEMI) is Associated With Worse Clinical Outcomes Than STEMI Due to Native Coronary Thrombosis. Circulation  vol. 124, (21)

Choudry FA and Mathur A (2011). Stem cell therapy in cardiology. Regenerative Medicine  vol. 6, (6 SUPPL.) 17-23. 10.2217/rme.11.57

Choudry FA and Mathur A (2011). Stem cell therapy in cardiology. Regen Med  vol. 6, (6 Suppl) 17-23. 10.2217/rme.11.57

Jones DA, Mathur A and Smith EJ (2011). Percutaneous treatment of a chronic total occlusion for ST segment elevation myocardial infarction: an alternative in the case of early graft failure. Heart  vol. 97, (18) 10.1136/heartjnl-2011-300261

Lovell MJ and Mathur A (2011). Republished review: Cardiac stem cell therapy: progress from the bench to bedside. Postgrad Med J  vol. 87, (1030) 558-564. 10.1136/pgmj.2009.192385rep

Rathod KS, Jones DA, Rathod VS, Guttmann O, Pimental C, Jain A, Mathur A, Knight C and Wragg A (2011). C-reactive protein as a predictor of MACE in primary PCI. European Heart Journal  vol. 32, 1059-1059.

Rathod KS, Jones DA, Rathod VS, Jain A, Mathur A, Knight C and Wragg A (2011). DES vs BMS in large coronary arteries during primary PCI. European Heart Journal  vol. 32, 956-956.

Sammut EC, Jones DA, Rathod K, Gallagher S, Graham A, Jain A, Knight C, Mathur A, Kapur A and Wragg A (2011). Prognostic value of baseline renal function on long term outcome in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. European Heart Journal  vol. 32, 188-188.

Monney PA, Sekhri N, Burchell T, Knight C, Davies C, Deaner A, Sheaf M, Baithun S, Petersen S, Wragg A, Jain A, Westwood M, Mills P, Mathur A and Mohiddin SA (2011). Acute myocarditis presenting as acute coronary syndrome: role of early cardiac magnetic resonance in its diagnosis. Heart  vol. 97, (16) 1312-1318. 10.1136/hrt.2010.204818

Jones D, Weerackody R, Rathod K, Jain A, Knight CJ, Kapur AK, Wragg A, Thompson CA, Mathur A and Smith EJ (2011). Successful recanalisation of Chronic Total Occlusions (CTO) is associated with increased long term survival. European Heart Journal  vol. 32, 246-247.

Mozid A, Arnous S, Yeo C, Brookman P, Preston M, Archbold A, Rothman M, Agrawal S, Martin J and Mathur A (2011). Head-to-head comparison of different delivery methods of autologous bone marrow progenitor cells in chronic ischaemic heart failure. European Heart Journal  vol. 32, 456-456.

Guttmann OP, Jones DA, Rathod K, Pain T, Jain A, Knight A, Mathur A and Wragg A (2011). In-stent restenosis is not simply a benign clinical entity as it presents as ACS in 40% of cases. European Heart Journal  vol. 32, 747-747.

Pain TE, Jones DA, Rathod K, Weerackody R, Gallagher S, Jain A, Knight C, Mathur A and Wragg A (2011). Treatment of multivessel coronary artery disease in primary PCI for ST elevation myocardial infarction: culprit only revascularisation is associated with higher MACE rates. European Heart Journal  vol. 32, 867-867.

Burchell TR, Davies LC, Mohiddin SA, Mathur A and Westwood MA (2011). The natural time-course of myocardial oedema in the first 3 months post ST-elevation MI in patients treated with primary angioplasty. European Heart Journal  vol. 32, 44-45.

Arnous S, Mozid A and Mathur A (2011). The Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy (REGENERATE-DCM) trial: study design. Regen Med  vol. 6, (4) 525-533. 10.2217/rme.11.29

Mozid AM, Arnous S, Sammut EC and Mathur A (2011). Stem cell therapy for heart diseases. Br Med Bull  vol. 98, 143-159. 10.1093/bmb/ldr014

Guttmann OP, Jones DA, Rathod K, Pain T, Jain A, Knight A, Mathur A and Wragg A (2011). In-stent restenosis is not simply a benign clinical entity as it presents as ACS in 40% of cases. American Journal of Respiratory and Critical Care Medicine  vol. 183, 747-747.

2010

Jones DA, Goddard I and Wragg A (2010). 18F-FDG positron emission tomography CT and assessment of aortitis. Heart  vol. 96, (23) 10.1136/hrt.2010.199166

Wong J, Mathur A, Mills PG, Boubertakh R, Uppal R, Wood A, Westwood M and Davies L (2010). Pre-operative ischaemia on CMR stress perfusion is a marker for prolonged post-operative stay after coronary artery bypass grafting. Journal of Cardiovascular Magnetic Resonance  vol. 12, (SUPPL. 1) 10.1186/1532-429X-12-S1-O39

Lovell MJ, Yasin M, Lee KL, Cheung KK, Shintani Y, Collino M, Sivarajah A, Leung K-Y, Takahashi K, Kapoor A, Yaqoob MM, Suzuki K, Lythgoe MF, Martin J, Munroe PB, Thiemermann C and Mathur A (2010). Bone marrow mononuclear cells reduce myocardial reperfusion injury by activating the PI3K/Akt survival pathway. Atherosclerosis  vol. 213, (1) 67-76. 10.1016/j.atherosclerosis.2010.07.045

Lovell MJ and Mathur A (2010). Cardiac stem cell therapy: progress from the bench to bedside. Heart  vol. 96, (19) 1531-1537. 10.1136/hrt.2009.192385

Lovell MJ, Yasin M, Lee KL, Cheung KK, Shintani Y, Collino M, Sivarajah A, Leung K, Takahashi K, Kapoor A, Yaqoob MM, Suzuki K, Lythgoe MF, Martin J, Munroe PB, Thiemermann C and Mathur A (2010). Bone marrow mononuclear cells reduce myocardial reperfusion injury by activating the PI3K/Akt survival pathway. Atherosclerosis  vol. 213, (1) 67-76. 10.1016/j.atherosclerosis.2010.07.045

2009

Mathur A (2009). Endothelial progenitor cells: trick or treat? Heart  vol. 95, (24) 10.1136/hrt.2009.174318

Martin-Rendon E, Brunskill S, Hyde C, Doree C, Mathur A and Taggart DP (2009). Stem cell therapy for ischaemic heart disease and congestive heart failure. Cochrane Database of Systematic Reviews  (3) 10.1002/14651858.CD007888

Page SP, Mcgill LA, Burchell TR, Davies C, Mathur A, Mills PG, Westwood MA and Mohiddin SA (2009). Magnetic resonance stress perfusion imaging in patients with left ventricular hypertrophy commonly detects perfusion defects and does not identify coronary disease. European Heart Journal  vol. 30, 550-551.

Page SP, Mcgill LA, Burchell TR, Mathur A, Davies C, Westwood MA, Mills PG and Mohiddin SA (2009). Fibrosis in left ventricular hypertrophy: cardiac magnetic resonance accurately distinguishes myocardial infarction from myopathic fibrosis. European Heart Journal  vol. 30, 256-256.

Yeo C, Saunders N, Locca D, Flett A, Preston M, Brookman P, Davy B, Mathur A and Agrawal S (2009). Ficoll-Paque versus Lymphoprep: a comparative study of two density gradient media for therapeutic bone marrow mononuclear cell preparations. Regen Med  vol. 4, (5) 689-696. 10.2217/rme.09.44

Flett AS, Westwood MA, Davies LC, Mathur A and Moon JC (2009). The prognostic implications of cardiovascular magnetic resonance. Circ Cardiovasc Imaging  vol. 2, (3) 243-250. 10.1161/CIRCIMAGING.108.840975

Kannan BRJ, Jain AK, Qureshi SA, Rothman MT, Rosenthal E and Mathur A (2009). Successful exclusion of large post-surgical pseudoaneurysms of the ascending aorta by a percutaneous approach. Ann Thorac Surg  vol. 87, (4) 1281-1284. 10.1016/j.athoracsur.2008.07.053

Jones DA, Walker F, Chopra NR, Serino W and Huwez F (2009). A woman with sudden headache followed by collapse. Bmj  vol. 338, 10.1136/bmj.b813

Chopra NR, Jones DA, Gadi N and Huwez F (2009). Sudden onset of pain in the eye and blurring of vision. Bmj  vol. 338, 10.1136/bmj.a3111

Yeo C and Mathur A (2009). Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial. Regen Med  vol. 4, (1) 119-127. 10.2217/17460751.4.1.119

2008

Mathur A and Lovell M (2008). Gene therapy and stem cell technology. Essential Interventional Cardiology  10.1016/B978-0-7020-2981-3.50041-6

Wragg A, Mellad JA, Beltran LE, Konoplyannikov M, San H, Boozer S, Deans RJ, Mathur A, Lederman RJ, Kovacic JC and Boehm M (2008). VEGFR1/CXCR4-positive progenitor cells modulate local inflammation and augment tissue perfusion by a SDF-1-dependent mechanism. J Mol Med (Berl)  vol. 86, (11) 1221-1232. 10.1007/s00109-008-0390-7

Martin-Rendon E, Brunskill S, Dorée C, Hyde C, Watt S, Mathur A and Stanworth S (2008). Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev  (4) 10.1002/14651858.CD006536.pub2

Roberts WT, Wright AR, Timmis JB, Junghans C, Jones DA, Jain AK, Smith EJ, Wragg A, Mathur A and Timmis AD (2008). No difference in diagnostic performance of coronary angiography and CT angiography for stent evaluation when set against IVUS gold-standard. European Heart Journal  vol. 29, 719-719.

Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A and Watt SM (2008). Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J  vol. 29, (15) 1807-1818. 10.1093/eurheartj/ehn220

Jones DA and Huwez F (2008). Don?t forget standing blood pressure. Bmj  vol. 336, (7640) 10.1136/bmj.39486.512639.3A

Jones DA and Huwez F (2008). Preventing falls: Don't forget standing blood pressure. Bmj  vol. 336, (7640) 10.1136/bmj.39486.512639.3A

Strange JW, Bucciarelli-Ducci C, Mathur A and Pennell DJ (2008). Images in cardiovascular medicine. Multiple coronary fistulae: a cause of subendocardial ischemia. Circulation  vol. 117, (6) 853-856. 10.1161/CIRCULATIONAHA.107.725515

2007

Martin-Rendon E, Brunskill S, Doree C, Hyde C, Watt S and Mathur A (2007). Stem cell treatment for acute myocardial infarction. Cochrane Database of Systematic Reviews  (2) 10.1002/14651858.CD006536

Jain AK and Mathur A (2007). Update on drug-eluting stents: as good as it gets? Clin Med (Lond)  vol. 7, (4) 401-404. 10.7861/clinmedicine.7-4-401

Koh TW and Mathur A (2007). Coronary stent fracture in a saphenous vein graft to right coronary artery - Successful treatment by the novel use of the Jomed coronary stent graft: Case report and review of tlie literature. Int J Cardiol  vol. 119, (2) E43-E45. 10.1016/j.ijcard.2007.01.106

2006

Astroulakis Z and Mathur A (2006). Images in cardiovascular medicine. Percutaneous intervention to a right coronary artery vein graft complicated by perforation into the right heart. Circulation  vol. 114, (17) e549-e550. 10.1161/CIRCULATIONAHA.106.626564

Astroulakis Z and Mathur A (2006). Percutaneous intervention to a right coronary artery vein graft complicated by perforation into the right heart. Circulation  vol. 114, (17) 10.1161/CIRCULATIONAHA.106.626564

Bartunek J, Dimmeler S, Drexler H, Fernandez-Aviles F, Galinanes M, Janssens S, Martin J, Mathur A, Menasche P, Priori S, Strauer B, Tendera M, Wijns W and Zeiher A (2006). The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Eur Heart J  vol. 27, (11) 1338-1340. 10.1093/eurheartj.ehi793

Grigoropoulos NF and Mathur A (2006). Stem cells in cardiac repair. Curr Opin Pharmacol  vol. 6, (2) 169-175. 10.1016/j.coph.2005.11.006

2005

Smith EJ, Mathur A and Rothman MT (2005). Recent advances in primary percutaneous intervention for acute myocardial infarction. Heart  vol. 91, (12) 1533-1536. 10.1136/hrt.2005.064493

Harrison P, Mackie I, Mathur A, Robinson MSC, Hong Y, Erusalimsky JD, Machin SJ and Martin JF (2005). Platelet hyper-function in acute coronary syndromes. Blood Coagul Fibrinolysis  vol. 16, (8) 557-562. 10.1097/01.mbc.0000187252.09759.ba

Lovell MJ, Ang R and Mathur A (2005). Models of cardiovascular disease in stem cell research. Drug Discovery Today: Disease Models  vol. 2, (3) 239-244. 10.1016/j.ddmod.2005.08.007

Scotland RS, Cohen M, Foster P, Lovell M, Mathur A, Ahluwalia A and Hobbs AJ (2005). C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression. Proc Natl Acad Sci U S A  vol. 102, (40) 14452-14457. 10.1073/pnas.0504961102

Monaco C, Mathur A and Martin JF (2005). What causes acute coronary syndromes? Applying Koch's postulates. Atherosclerosis  vol. 179, (1) 1-15. 10.1016/j.atherosclerosis.2004.10.022

MATHUR A, Lovell MJ and Ginks M (2005). Adult stem cells and their role in the treatment of heart disease. Heart Failure & Hypertension Abstracts  vol. 35, 4-8.

Harrison P, Mackie I, Mathur A, Robinson MSC, Hong Y, Erusalimsky JD, Machin SJ and Martin JF (2005). Platelet hyper-function in acute coronary syndromes. Blood Coagul Fibrinolysis  vol. 16, (8) 557-562.

2004

Mathur A and Martin JF (2004). Stem cells and repair of the heart. Lancet  vol. 364, (9429) 183-192. 10.1016/S0140-6736(04)16632-4

Ahluwalia A, Foster P, Scotland RS, McLean PG, Mathur A, Perretti M, Moncada S and Hobbs AJ (2004). Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment. Proc Natl Acad Sci U S A  vol. 101, (5) 1386-1391. 10.1073/pnas.0304264101

Lovell MJ and Mathur A (2004). The role of stem cells for treatment of cardiovascular disease. Cell Prolif  vol. 37, (1) 67-87. 10.1111/j.1365-2184.2004.00301.x

Mathur A, Duke T, Kukuruzovic R and South M (2004). Hypotonic vs isotonic saline solutions for intravenous fluid management of acute infections. Cochrane Database Syst Rev  (2) 10.1002/14651858.CD004169.pub2

Mathur A, Hong Y, Wang G and Erusalimsky JD (2004). Assays of megakaryocyte development: surface antigen expression, ploidy, and size. Methods Mol Biol  vol. 272, 309-322. 10.1385/1-59259-782-3:309

2003

Cotton JM, Hong Y, Hawe E, Mathur A, Humphries SE, Brown AS, Martin JF and Erusalimsky JD (2003). Rise of circulating thrombopoietin following cardiothoracic surgery is potentiated in patients with coronary atherosclerosis: correlation with a preceding increase in levels of interleukin-6. Thromb Haemost  vol. 89, (3) 538-543. 10.1055/s-0037-1613385

Cotton JM, Hong Y, Hawe E, Mathur A, Humphries SE, Brown AS, Martin JF and Erusalimsky JD (2003). Rise of circulating thrombopoietin following cardiothoracic surgery is potentiated in patients with coronary atherosclerosis: correlation with a preceding increase in levels of interleukin-6. Thromb Haemost  vol. 89, (3) 538-543. 10.1267/THRO03030538

2002

Cotton JM, Mathur A, Hong Y, Brown AS, Martin JF and Erusalimsky JD (2002). Acute rise of circulating vascular endothelial growth factor-A in patients with coronary artery disease following cardiothoracic surgery. Eur Heart J  vol. 23, (12) 953-959. 10.1053/euhj.2001.3034

Mohamed-Ali V, Goodrick SJ, Erusalimsky JD, Mathur A, Sharpe M and Duchen MR (2002). Redox state, mitochondrial membrane potential and UCP expression in relation to lipid content in adipocytes. Biophys J  vol. 82, (1) 344A-344A.

2001

Mathur A, Robinson MS, Cotton J, Martin JF and Erusalimsky JD (2001). Platelet reactivity in acute coronary syndromes: evidence for differences in platelet behaviour between unstable angina and myocardial infarction. Thromb Haemost  vol. 85, (6) 989-994. 10.1055/s-0037-1615952

Mathur A, Hong Y, Martin J and Erusalimsky J (2001). Megakaryocytic differentiation is accompanied by a reduction in cell migratory potential. Br J Haematol  vol. 112, (2) 459-465. 10.1046/j.1365-2141.2001.02534.x

2000

Beltran B, Mathur A, Duchen MR, Erusalimsky JD and Moncada S (2000). The effect of nitric oxide on cell respiration: A key to understanding its role in cell survival or death. P Natl Acad Sci Usa  vol. 97, (26) 14602-14607. 10.1073/pnas.97.26.14602

Mathur A, Hong Y, Kemp BK, Barrientos AA and Erusalimsky JD (2000). Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes. Cardiovasc Res  vol. 46, (1) 126-138. 10.1016/S0008-6363(00)00002-X

Zachary I, Mathur A, Yla-Herttuala S and Martin J (2000). Vascular protection: A novel nonangiogenic cardiovascular role for vascular endothelial growth factor. Arterioscler Thromb Vasc Biol  vol. 20, (6) 1512-1520. 10.1161/01.ATV.20.6.1512

Cotton JM, Webb KE, Mathur A, Martin JF and Humphries SE (2000). Impact of the -455G>A promoter polymorphism in the B fibrinogen gene on stimulated fibrinogen production following bypass surgery. Thromb Haemost  vol. 84, (5) 926-927. 10.1055/s-0037-1614144

1999

Genever PG, Wilkinson DJ, Patton AJ, Peet NM, Hong Y, Mathur A, Erusalimsky JD and Skerry TM (1999). Expression of a functional N-methyl-D-aspartate-type glutamate receptor by bone marrow megakaryocytes. Blood  vol. 93, (9) 2876-2883.

Martin JF, Smith RE and Mathur A (1999). Endogenous mediators and thrombophilia. Baillieres Best Pract Res Clin Haematol  vol. 12, (3) 373-386. 10.1053/beha.1999.0031

^ Back to Top